Riskpilot← Back to searchSign inGet full accessAmferia AB
ABActiveOrg 5591701262Az Bioventurehub AstrazenecaManufacture of medical and dental instruments and supplies · NACE 3250Est. 201810-19 employees
Revenue 2024
SEK 3,9M
+11418% vs 2023
EBITDA margin
-190.6%
-28% vs 2023
Equity ratio
88.8%
Financial strength
Net profit 2024
SEK -8,2M
-39% vs 2023
| Revenue | SEK 3,9M | +11418% |
| EBITDA | SEK -7,5M | -28% |
| Net profit | SEK -8,2M | -39% |
| Total assets | SEK 21,5M | +37% |
| Equity | SEK 19,1M | +39% |
| Employees | — | — |
Legal name
Amferia AB
Org number
5591701262
Legal form
Aktiebolag
NACE code
3250 · Manufacture of medical and dental instruments and supplies
Founded
4 september 2018
Share capital
SEK 141 000
Employees
10-19
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas två i förening av ledamöterna Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Aktiebolaget ska tillhandahålla medicintekniskt material för behandling samt för förebyggande av bakteriella infektioner.
Address
Az Bioventurehub Astrazeneca
Email
anand9007@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 34 | 3 916 |
| Staff expenses | — | — | — | — | — | — |
| EBITDA | −99 | −2 607 | −3 152 | −4 778 | −5 852 | −7 462 |
| Depreciation & amort. | −1 | −19 | −66 | −138 | −180 | −849 |
| EBIT | −100 | −2 626 | −3 218 | −4 916 | −6 032 | −8 311 |
| Net financials | −3 | −16 | −32 | −47 | 161 | 123 |
| Profit before tax | −103 | −2 641 | −3 250 | −4 962 | −5 872 | −8 188 |
| Tax | −0 | −0 | −0 | −0 | −0 | −0 |
| Net profit | −103 | −2 641 | −3 250 | −4 962 | −5 872 | −8 188 |
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Total assets | 6 780 | 5 198 | 10 559 | 20 071 | 15 654 | 21 508 |
| Equity | 6 272 | 3 631 | 8 778 | 18 145 | 13 773 | 19 098 |
| Long-term debt | 300 | 1 011 | 950 | 830 | 710 | 597 |
| Short-term debt | 208 | 556 | 831 | 1 095 | 1 172 | 1 814 |
| Total debt | 508 | 1 567 | 1 781 | 1 925 | 1 882 | 2 411 |
EBITDA margin
-190.6%
This company
15.8%
Market median
-1306% vs market
20192024
Equity ratio
88.8%
This company
38.2%
Market median
+132% vs market
20192024
Return on equity
-42.9%
This company
18.4%
Market median
-333% vs market
20192024
Net profit margin
-209.1%
This company
8.1%
Market median
-2681% vs market
20192024
Asset turnover
0.18×
This company
1.12×
Market median
-84% vs market
20192024
Debt / equity
0.13×
This company
0.62×
Market median
+79% vs market
20192024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2018-09-01 – 2019-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
CF Chief Auditor | Chief Auditor | 2020 | — | — |
AK Chief Executive Officer | Chief Executive Officer | 2020 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2020 | — | — | |
| Board of Directors | 2022 | — | — | |
| Board of Directors | 2021 | — | — | |
| Board of Directors | 2020 | — | — | |
| Board of Directors | 2021 | — | — | |
| Board of Directors | 2025 | — | — | |
| Board of Directors | 2020 | — | — | |
| Chairman | 2022 | — | — | |
| Board of Directors | 2021 | — | — | |
| Board of Directors | 2020 | — | — | |
| Board of Directors | 2020 | — | — | |
| Board of Directors | 2025 | — | — | |
| Board of Directors | 2022 | — | — | |
| Board of Directors | 2022 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Amferia AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Carl Fredrik Johan Gustav Waern | Chief Auditor | 0 companies |
| Anand Kumar Rajasekharan | Chief Executive Officer | 0 companies |
| Raymond Butler | Board of Directors | 0 companies |
| Louise Anna Warme | Board of Directors | 0 companies |
| Karin Ulrika Ågren | Board of Directors | 0 companies |
| David Jan Storek | Board of Directors | 0 companies |
| Frida Birgitta Wallin Sahlberg | Board of Directors | 0 companies |
| Anders Birger Husmark | Board of Directors | 0 companies |
| Sven Tiberiu Cristea | Board of Directors | 0 companies |
| Eva Agneta Edberg | Chairman | 0 companies |
| Björn Engström | Board of Directors | 0 companies |
| Per Johan Martin Andersson | Board of Directors | 0 companies |
| P Alexandra M De Wever Treschow | Board of Directors | 0 companies |
| Per Henrik Jansson | Board of Directors | 0 companies |
| Saba Atefyekta | Board of Directors | 0 companies |
| Jonas Olof Bergman | Board of Directors | 0 companies |